Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 408
Selected: 0
NCT IDTitle
NCT04984811NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
NCT03779191Alectinib in Combination With Bevacizumab in ALK Positive NSCLC
NCT01752335Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis
NCT01683175Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation
NCT01456312HBsAg Related Response Guided Therapy
NCT04148066ctDNA Guided Treatment of Early Resistance to Targeted Treatment
NCT00205556Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis Patients
NCT00457301Using Health-related Quality of Life (HRQL) in Routine Clinical Care
NCT03767075A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)
NCT05911178Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease
NCT04335071Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)
NCT01729481Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer
NCT00074438Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis
NCT00744640Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma
NCT01259817Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
NCT00433589Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes
NCT01524679Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen
NCT00215982Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer
NCT01326559Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)
NCT03341520Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma
NCT03385668Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies
NCT02992704Peg-interferon for Inactive Chronic Hepatitis B Carriers
NCT03679455A Study of Obinutuzumab (RO5072759) Induction in Patients With Relapsed/ Refractory Waldenström Macroglobulinemia, OBI-1
NCT01368848Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)
NCT01569984Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis
NCT02169349Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer
NCT00333437Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement
NCT05470595A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung
NCT01126866Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy
NCT05396937Efficacy and Safety of T+A+RAD in HCC
NCT03147040AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer
NCT02569736Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation
NCT01723111Impact of Dialysis Modality on Hepcidin and Iron Metabolism
NCT05057234PRecision Oncology Evidence Development in Cancer Treatment - Liquid
NCT05293015NP-Supported Multidisciplinary Diabetes Management During Perioperative Period
NCT01718379Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.
NCT04920981Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
NCT04490044Under and Over Rehabilitation Study
NCT00440167Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine
NCT03134794Medical Education for Better Multiple Sclerosis Outcomes
NCT00562770Oral Valganciclovir Versus Valacyclovir
NCT05919342Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
NCT04363853Tocilizumab Treatment in Patients With COVID-19
NCT02790645Telemedicine Program in Type 1 Diabetes and CSII
NCT01652560Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
NCT01508000Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases
NCT00275665The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection.
NCT05839145Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study
NCT00079053Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT014174941st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer